http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101990054-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 |
| filingDate | 2017-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101990054-B1 |
| titleOfInvention | Anti-cancer Composition Comprising Lawsone |
| abstract | The present invention relates to a pharmaceutical composition for preventing or treating cancer comprising Lawson as an active ingredient. The present invention also relates to a food composition and a feed composition for preventing or ameliorating cancer comprising Lawson as an active ingredient. According to the present invention, lawson (2-hydroxy-1,4-naphthoquinone) (HNQ) decreases the viability of HeLa cervical cancer cells, induces apoptosis by cytotoxicity, causes cell cycle arrest and senescence , Leading to apoptotic pathways. Lawson showed the effect of reducing tumor formation in xenotransplantation nude mice. Thus, it is expected that Lawson according to the present invention can be used as a natural agent for treating cancer, particularly, cervical cancer. |
| priorityDate | 2017-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 340.